Search Tag: nervous system
2022 21 Jul
Company Continues Commercial Preparations in Advance of Phase III Clinical Trial Readouts for REL-1017 in Major Depressive Disorder Expected in 2022 Relmada Therapeutics, Inc., a late-stage biotechnology company addressing diseases of the central nervous system (CNS) announced the appointment of John Hixon to a newly created position as Head...Read more